<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Ehrlich Ascites Carcinoma &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/ehrlich-ascites-carcinoma/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 13 Jan 2026 07:33:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Ehrlich Ascites Carcinoma &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Hesperidin Nanoparticles Boost Kidney and Cancer Defense</title>
		<link>https://bioengineer.org/hesperidin-nanoparticles-boost-kidney-and-cancer-defense/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jan 2026 07:32:39 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Antitumor Effects]]></category>
		<category><![CDATA[Ehrlich Ascites Carcinoma]]></category>
		<category><![CDATA[Hesperidin Nanoparticles]]></category>
		<category><![CDATA[Nanoparticle drug delivery]]></category>
		<category><![CDATA[Renal protection]]></category>
		<guid isPermaLink="false">https://bioengineer.org/hesperidin-nanoparticles-boost-kidney-and-cancer-defense/</guid>

					<description><![CDATA[In a significant breakthrough that merges the fields of oncology and nephrology, researchers have unveiled promising therapeutic potential of hesperidin nanoparticles in combating Ehrlich ascites carcinoma while simultaneously protecting renal function. This pioneering study, recently published in Medical Oncology, explores the multifaceted mechanisms by which these nanoparticles exert antitumor efficacy coupled with renal protection, offering [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">316394</post-id>	</item>
	</channel>
</rss>
